The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro
Open accessAbstract
Background —Unstable atherosclerotic plaques that cause acute coronary events usually contain abundant macrophages expressing matrix metalloproteinases (MMPs) and tissue factor (TF), molecules that probably contribute to plaque rupture and subsequent thrombus formation. Lipid lowering with HMG-CoA reductase inhibitors reduces acute coronary events. Methods and Results —To test whether lipid lowering with an HMG-CoA reductase inhibitor retards macrophage accumulation in rabbit atheroma, we administered cerivastatin to immature Watanabe heritable hyperlipidemic rabbits (cerivastatin group, n=10, cerivastatin 0.6 mg · kg −1 · d −1 ; control group, n=9, saline 0.6 mL · kg −1 · d −1 ) for 32 weeks and measured macrophage accumulation and expression of MMPs and TF. Serum cholesterol levels after 32 weeks were 809±40 mg/dL (control group) and 481±24 mg/dL (treated group). Cerivastatin diminished accumulation of macrophages in aortic atheroma. Macrophage expression of MMP-1, MMP-3, MMP-9, and TF also decreased with cerivastatin treatment. Cerivastatin reduced the number of macrophages expressing histone mRNA (a sensitive marker of cell proliferation) detected by in situ hybridization but did not alter macrophages bearing a marker of death (TUNEL staining). Cerivastatin treatment (≥0.01 μmol/L) also reduced growth, proteolytic activity due to MMP-9, and TF expression in cultured human monocyte/macrophages. Conclusions —These results suggest that lipid lowering with HMG-CoA reductase inhibitors alters plaque biology by reducing proliferation and activation of macrophages, prominent sources of molecules responsible for plaque instability and thrombogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Self-citationMolecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Self-citationLocalization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.
Moreno, P. R., Falk, E., Palacios, I. F., Newell, J. B., Fuster, V, & Fallon, J. T. (1994) · Circulation · doi:10.1161/01.cir.90.2.775 · Cited by 1,108
Metcalf, D. (1989) · Nature · doi:10.1038/339027a0 · Cited by 1,023
Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.
Henney, A. M., Wakeley, P. R., Davies, M. J., Foster, K., Hembry, R., Murphy, G., & Humphries, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8154 · Cited by 590
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 574
Aikawa, M., Rabkin, E., Okada, Y., Voglic, S. J., Clinton, S. K., Brinckerhoff, C. E., Sukhova, G. K., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.97.24.2433 · Cited by 555
Self-citationCell proliferation in human coronary arteries.
Gordon, D., Reidy, M. A., Benditt, E. P., & Schwartz, S. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4600 · Cited by 532
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
Self-citationMacrophages and atherosclerotic plaque stability
Libby, P., Geng, Y. J., Aikawa, M., Schoenbeck, U., Mach, F., Clinton, S. K., Sukhova, G. K., & Lee, R. T. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199610000-00012 · Cited by 480
Self-citationHeintz, N., Sive, H. L., & Roeder, R. G. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.4.539 · Cited by 470
Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis
Nikkari, S. T., O’Brien, K. D., Ferguson, M., Hatsukami, T., Welgus, H. G., Alpers, C. E., & Clowes, A. W. (1995) · Circulation · doi:10.1161/01.cir.92.6.1393 · Cited by 396
Guijarro, C., Blanco-Colio, L. M., Ortego, M., Alonso, C., Ortiz, A., Plaza, J. J., Díaz, C., Hernández, G., & Egido, J. (1998) · Circulation Research · doi:10.1161/01.res.83.5.490 · Cited by 390
Colli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., & Tremoli, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.265 · Cited by 348
Rosenfeld, M. E., & Ross, R. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.5.680 · Cited by 331
Becker, S., Warren, M. K., & Haskill, S. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3703 · Cited by 263
Low-density lipoprotein-independent effects of statins
Davignon, J., & Laaksonen, R. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00010 · Cited by 244
Tissue Factor in the Pathogenesis of Atherosclerosis
Taubman, M. B., Fallon, J. T., Schecter, A. D., Giesen, P., Mendlowitz, M., Fyfe, B. S., Marmur, J. D., & Nemerson, Y. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657526 · Cited by 193
Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study
Campbell, T. C., Parpia, B., & Chen, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00718-8 · Cited by 177
Rekhter, M. D., & Gordon, D. (1995) · PubMed · Cited by 154
Dietary Lipid Lowering Reduces Tissue Factor Expression in Rabbit Atheroma
Aikawa, M., Voglic, S. J., Sugiyama, S., Aïkawa, E., Taubman, M. B., Fallon, J. T., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.100.11.1215 · Cited by 141
Self-citationAikawa, M., Aïkawa, E., Voglic, S. J., Shing, H., Nagai, R., Schöen, F. J., & Libby, P. (1998) · Circulation Research · doi:10.1161/01.res.83.10.1015 · Cited by 140
Self-citationHamilton, J. A., Myers, D. E., Jessup, W., Cochrane, F., Byrne, R. A., Whitty, G. A., & Moss, S. T. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.98 · Cited by 137
Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits
Kockx, M. M., Meyer, G. R. Y. D., Muhring, J., Bult, H., Bultinck, J., & Herman, A. G. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05691-2 · Cited by 108
New Insights into Plaque Stabilisation by Lipid Lowering
Libby, P., & Aikawa, M. (1998) · Drugs · doi:10.2165/00003495-199856001-00002 · Cited by 105
Self-citationHMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein
Sakai, M., Kobori, S., Matsumura, T., Biwa, T., Sato, Y., Takemura, T., Hakamata, H., Horiuchi, S., & Shichiri, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00118-4 · Cited by 83
Sakai, M., Miyazaki, A., Hakamata, H., Sato, Y., Matsumura, T., Kobori, S., Shichiri, M., & Horiuchi, S. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.4.600 · Cited by 77
Shiomi, M., & Ito, T. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702382 · Cited by 65
Self-citationIgarashi, M., Takeda, Y., Mori, S., Ishibashi, N., 小松, 栄., Takahashi, K., Fuse, T., Yamamura, M., Kubo, K., Sugiyama, Y., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701018 · Cited by 46
Stein, E. A., Isaacsohn, J. L., Stoltz, R. R., Mazzu, A. L., Liu, M.-C., Lane, C., & Heller, A. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00120-4 · Cited by 45
Preclinical and clinical pharmacology of cerivastatin
Bischoff, H., & Heller, A. H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00433-0 · Cited by 43
Corsini, A. (1996) · Pharmacological Research · doi:10.1006/phrs.1996.0009 · Cited by 42
Lewis, R. P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)80039-x · Cited by 31
Preclinical review of cerivastatin sodium—a step forward in HMG-CoA reductase inhibition
Bischoff, H., Angerbauer, R., Boberg, M., Petzinna, D., Schmidt, D. D., Steinke, W., & Thomas, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00188-9 · Cited by 19
Cited by
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Self-citationInflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Self-citationInflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Self-citationPLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Metadata
- Authors
- Aikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P.
- Venue
- Circulation
- Published
- 2001-01-16
- Volume
- 103
- Issue
- 2
- Pages
- 276-283
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2112098540
- Cited by
- 588
- References
- 38
- FWCI
- 17.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.